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Deletions of cryptococcal PIK1, RUB1, and ENA1
genes independently rendered defects in yeast sur-
vival in human CSF and within macrophages. We eval-
uated virulence potential of these genes by comparing
wild-type Cryptococcus neoformans strain H99 with
deletant and complement strains in a BALB/c mouse
model of pulmonary infection. Survival of infected
mice; pulmonary cryptococcal growth and pathology;
immunological parameters; dissemination kinetics;
and CNS pathology were examined. Deletion of each
PIK1, RUB1, and ENA1 differentially reduced pulmo-
nary growth and dissemination rates of C. neofor-
mans and extended mice survival. Furthermore,
pik1 induced similar pathologies to H99, however,
with significantly delayed onset; rub1 was more ef-
ficiently contained within pulmonary macrophages
and was further delayed in causing CNS dissemina-
tion/pathology; whereas ena1 was progressively
eliminated from the lungs and did not induce patho-
logical lesions or disseminate into the CNS. The di-
minished virulence of mutant strains was associated
with differential modulation of pulmonary immune
responses, including changes in leukocyte subsets,
cytokine responses, and macrophage activation sta-
tus. Compared to H99 infection, mutants induced
more hallmarks of a protective Th1 immune re-
sponse, rather than Th2, and more classical, rather
than alternative, macrophage activation. The mag-
1356nitude of immunological effects precisely corre-
sponded to the level of virulence displayed by each
strain. Thus, cryptococcal PIK1, RUB1, and ENA1 dif-
ferentially contribute to cryptococcal virulence, in
correlation with their differential capacity to modu-
late immune responses. (Am J Pathol 2012, 181:1356–
1366; http://dx.doi.org/10.1016/j.ajpath.2012.06.012)
Cryptococcal infections are a major cause of meningo-
encephalitis-related deaths in immunocompromised
hosts, but are also increasingly found in immunocompe-
tent hosts. The successful clearance of Cryptococcus
neoformans in the lungs and the prevention of systemic
dissemination depend on the effector function of pulmo-
nary CD4 and CD8 T cells and protective Th1 immune
polarization, whereas the development of Th2 polariza-
tion is nonprotective.1–5 Our studies demonstrate that the
overall balance between multiple Th cytokine responses in
the C. neoformans–infected lungs translates into different
spectra of macrophage activation.6–9 The M1-type macro-
phage activation, also referred to as classical activation, is
driven by Th1 signals and is characterized by up-regulation
of inducible nitric oxide synthase (iNOS)—an inducer of the
fungicidal nitric oxide.6,9–12 The M2-type macrophage ac-
tivation, also referred to as alternative activation, is driven by
Th2 signals and is characterized by strong up-regulation of
arginase (ARG1), which metabolizes arginine without
yielding fungicidal nitric oxide.6,7,9–11 Thus, M1 macro-
phages serve as fungicidal effector cells, whereas M2
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neoformans and harbor live/proliferating fungus.6,7,9–11
Apart from the distinct M1 and M2 phenotypes, interme-
diately activated macrophages that concurrently up-reg-
ulate Arg1 and iNOS were reported in the context of chronic
cryptococcal infection, in which yeasts are contained, but not
cleared, from lungs.6,7,9–11 Collectively, these studies un-
derscore the role of macrophage activation status as a
crucial determinant of clearance, persistence, or progres-
sion of C. neoformans infection.
Apart from the effects of host immune status, quantitative
differences in the expression of multiple virulence factors
define the ability of C. neoformans to persist in the infected
host and to cause central nervous system (CNS) dissemi-
nation.13,14 Some of these factors have been shown to pro-
mote crucial steps in the pathogenesis of the yeast such as
ability to grow in the lungs, disseminate from the lungs into
other organs and tissues, and/or survive within the
CNS.15–20 Although mechanisms of virulence for some fac-
tors have been at least partially clarified, and dozens of
novel virulence factor candidate genes in C. neoformans
have been identified, little is known about their role in the
pathogenesis of cryptococcosis.13,16,17,21–23
To establish the role and/or mechanism of each poten-
tial virulence factor and facilitate the process of virulence
evaluation, a variety of high-throughput methods has
been introduced.14,24–27 These assays are important ini-
tial screening devices; however, it is not clear whether
their outcomes translate into the global virulence in the
infected host. On one hand, a correlation between the
outcome of C. neoformans screening in macrophage co-
culture assay and survival times of mice infected with
different strains was reported.28–30 On the other hand,
cryptococcal virulence attributes are also linked to their
ability to inhibit T-cell responses and promote a nonprotec-
tive Th bias4,15,16,31,32 and/or to display high CNS tro-
pism.16,19,33 Some of the latter mechanisms are likely to be
unrelated to cryptococcal fitness in the macrophage co-
culture and/or other simplified screening assays.
A recent global mutant screen study identified many
cryptococcal genes with a possible role in cryptococcal
growth and virulence.24 Three mutants with independent
deletions of three cryptococcal genes encoding a cation
ATPase transporter (ENA1), a ubiquitin-like protein (RUB1),
and a phosphatidylinositol 4-kinase (PIK1) were selected for
further studies; these mutants showed dramatically im-
paired survival in human cerebral spinal fluid (CSF) but
retained the ability to grow in minimal media,24 suggesting
virulence-specific defects, rather than simply impaired gen-
eral viability. The mutants also demonstrated differentially
decreased virulence in a rabbit model of meningitis and an
invertebrate model of infection, and varied in fitness in a
macrophage killing assay in vitro. Interestingly, the level of
attenuation found for each mutant varied from assay to
assay and/or at different time points. Thus, the role of these
genes in pathogenesis, including primary lung infection,
extrapulmonary dissemination, and eventual CNS coloniza-
tion, needed to be evaluated in a relevant animal model.
The objective of the present study was to evaluate the
effect of these mutations in the natural course of infection
in a mouse model. We report that deletion of each ofthese cryptococcal genes differentially affected the
course of pulmonary infection, extrapulmonary dissemi-
nation, and lung and brain pathology. These effects fre-
quently deviated from the outcomes of simplified screen-
ing assays performed with these strains, but matched
well with the changes in immunological processes we
observed in the infected mice.
Materials and Methods
C. neoformans Strains
Deletant and complement strains were generated in
J.R.P.’s laboratory from the wild-type C. neoformans H99
strain (ATCC 208821) as described previously.14,24–27
The null mutants had deleted: pik1, a 1-phosphatidyl-
inositol 4-kinase; rub1, a ubiquitin-like protein; and
ena1, a P-type ATPase cation transporter. Reconsti-
tuted strains pik1::PIK1, rub1::RUB1, and ena1::ENA1
represent each null mutant strain with an appropriate
wild-type copy of PIK1, RUB1, or ENA1 reintroduced.
Reconstitution was performed similarly to the previously
described generation of the reconstituted ena1::ENA1
strain14,24–27 and confirmed by PCR, Southern hybridiza-
tion, and growth in CSF. For infections, yeast were grown
to stationary phase in Sabouraud Dextrose Broth (Difco,
Detroit, MI) on a shaker for 72 hours at 37°C, washed
twice with saline, counted on a hemocytometer, and then
adjusted to the inoculum concentration.
Mice
All experimental procedures were approved by the VA and
Duke University institutional animal care and use commit-
tees. Female wild-type BALB/c mice were obtained from
Jackson Laboratories (Bar Harbor, ME). Mice were raised in
specific-pathogen–free conditions in cages covered with a
filter top and were fed sterile food/water ad libitum. Six- to
10-week-old mice were inoculated intranasally with 2 104
C. neoformans cells in a volume of 30 L. Mice were hu-
manely euthanized by CO2 inhalation.
Colony-Forming Unit Assay
Lung, brain, and spleen tissues were homogenized in 2
mL of sterile water. Serial 10-fold dilutions of the samples
were plated in duplicates of 10-L aliquots on Sabouraud
Dextrose Agar and incubated at room temperature for 3
days. C. neoformans colonies were counted and ex-
pressed as colony-forming units per organ.
Lung Leukocyte Isolation
The lungs from each mouse were excised, washed in
RPMI, dispersed using enzymatic digest procedure, and
cells isolated as described previously.4–7,10,12 Leukocyte
pellets were suspended in 5 mL of complete RPMI me-
dium and enumerated on a hemocytometer following di-
lution in trypan blue (Sigma, St. Louis, MO).
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All staining reactions were performed according to the
manufacturers’ protocols. Data were collected on a FACS
LSR II flow cytometer using FACSDiva software (BD Bio-
sciences, San Jose, CA) and analyzed using FlowJo soft-
ware (Tree Star, San Carlos, CA). A minimum of 30,000
cells were analyzed per sample. Initial gates were set
based on light-scatter characteristics and CD45 staining.
Lymphocytes in the preselected CD45 cell population
were gated on forward and side scatter plots; small cells
were selected by using anti-CD3 (for T cells), and sub-
sets were identified using anti-CD8 and anti-CD4 anti-
bodies.4,5 All antibody reagents were purchased from
BioLegend (San Diego, CA).
Visual Identification of Leukocyte Populations
Macrophages, neutrophils, eosinophils, monocytes, and
lymphocytes were counted in Wright-Giemsa–stained
samples of lung cell suspensions cytospun onto glass
slides. Samples were fixed, stained, and then counted
under a microscope as described previously.4,5,7,10 The
percentages of leukocyte subsets were multiplied by the
total number of leukocytes to calculate absolute numbers
in the sample.
Isolation of RNA from Pulmonary Leukocytes or
Adherence-Enriched Pulmonary Macrophages
Isolated pulmonary leukocytes (10  106 cells/mL) were
seeded in six-well plates and cultured at 37°C, 5% CO2
for 1.5 hours. Plates were washed twice using PBS to
remove all nonadherent and loosely adherent cells. Total
RNA was collected from fresh pulmonary leukocytes or
adherent cells, and used for real-time reverse transcrip-
tion and quantitative PCR analyses.7
Real-Time PCR
Total RNA was prepared using RNeasyPlus Mini Kit (Qia-
gen, Valencia, CA), and first-strand cDNA was synthe-
sized using QuantiTect Reverse Transcription Kit (Qia-
gen) according to the manufacturer’s instructions.
Cytokine mRNA was quantified with SYBR Green–based
detection using an MX 3000P system (Stratagene, La
Jolla, CA) according to the manufacturer’s protocols.
Forty cycles of PCR (94°C for 15 seconds followed by
60°C for 30 seconds and 72°C for 30 seconds) were
performed on a cDNA template. The primer sets used
were previously published sequences.9,11,34–37 The
mRNA levels were normalized to glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) mRNA levels and rela-
tive expression shown as % of GAPDH.
Histological Analysis
Lungs were fixed by inflation with 1 mL of 10% neutral
buffered formalin, excised, and then immersed in neutral
buffered formalin. After paraffin embedding, 5-m sec-tions were cut and stained with mucicarmine with H&E
counterstain. Sections were analyzed with light micros-
copy, and microphotographs were taken using Digital
Microphotography system DFX1200 with ACT-1 software
(Nikon, Tokyo, Japan).
Calculations and Statistics
All values are reported as means  standard errors (SEM).
Statistical significance was calculated using one-way anal-
ysis of variance whenever multiple groups were compared.
For individual comparisons of multiple groups, Student-
Newman-Keuls post hoc test was used to calculate P val-
ues. Survival study comparisons were performed using Ka-
plan-Meier analysis. Means with P values of 0.05 were
considered significantly different. All statistical calculations
were performed using Primer of Biostatistics.38
Results
Cryptococcal Genes PIK1, RUB1, and ENA1
Differentially Promote C. neoformans Virulence
in a Mouse Model of Pulmonary Infection
Deletion of cryptococcal genes PIK1, RUB1, and ENA1
leads independently to dramatically reduced survival of
the deletant strains in human CSF fluid.14,24–27 To deter-
mine whether independent deletion of these genes would
render these strains avirulent in a murine model of pul-
monary infection, BALB/c mice were infected with one of
the following strains: null mutants pik1, rub1, and
ena1; complemented strains pik1::PIK1, rub1::RUB1,
ena1::ENA1; or the wild-type H99 via intranasal instilla-
tion of 2  104 cells. Survival of mice was assessed daily
for up to 60 days postinfection (dpi).
Deletion of PIK1, RUB1, and ENA1 genes resulted in a
significantly reduced virulence of the fungus and im-
proved survival time of the infected mice (Figure 1). Com-
pared to H99 infection with the median survival time of 22
dpi and 100% mouse mortality by 25 dpi, the pik1 mu-
tant showed the least attenuated virulence (median sur-
vival time of 48 dpi and 90% mortality by 60 dpi, Figure
1A), rub1 showed intermediate attenuation (median sur-
vival time of 55.5 dpi and 60% mortality, Figure 1B), and
ena1 showed the greatest attenuation with 0% mortality
over 60 dpi (Figure 1C). Complementation of the deleted
genes in each of the mutant strains virtually restored the
original virulence to the level of the wild-type strain H99.
The median survival time of mice infected with
pik1::PIK1, rub1::RUB1, or ena1::ENA1 was 28, 27,
and 28 days, respectively, indicating that the attenuated
virulence observed in each of the deletant strains was
associated specifically with the deletion of the desig-
nated gene. Thus, cryptococcal expression of PIK1,
RUB1, and ENA1 genes independently contribute to
cryptococcal disease.
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Have a Differential Impact on Pulmonary
Control of C. neoformans
To determine whether the improved survival of themice was
linked to decreased pulmonary growth of C. neoformans
mutants, fungal burdens were evaluated at 3, 7, 14, 21 dpi,
and postmortem. Consistent with the survival data, all
deletant strains showed decreased pulmonary growth
rate compared to the wild-type strain H99 (Figure 2, A–C);
furthermore, the extent of pulmonary growth reduction
corresponded to attenuation level of each mutant defined
by the survival study. Compared to H99, pik1, rub1,
and ena1 strains all showed significantly lower lung
burden, beginning from day 3 to 21, with: pik1 showing
slower but progressive growth and lung burden compa-
rable to that of H99-infected mice postmortem (Figure
2A); rub1 showing even slower and stepwise growth
dynamics with lower burden in mice that survived 60 dpi
and comparable fungal burdens in mice that succumbed
to the infection (Figure 2B); ena1 showing the most
significant growth inhibition and a trend toward complete
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Figure 1. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on mice
survival following pulmonary C. neoformans infection. BALB/c mice were
infected intranasally with 2  104 cells of three mutant strains, pik1, rub1,
and ena1, matching complement strains pik1::PIK1, rub1::RUB1, and
ena1::ENA1, or H99 wild-type strain. Mice were observed daily, and mor-
ibund animals were humanely euthanized and survival data recorded. Note
improvement of survival time in the infected mice with pik1 showing the
least attenuated virulence (A); rub1 showing intermediate virulence (B);
and ena1 showing the most profound effect with no mortality over 60 days
(C). All of the survival curves of complement strains are significantly different
from their corresponding deletant strains, demonstrating that observed at-
tenuation was gene specific for each mutant. The plots show data pulled
from at least two independent experiments expressed as percentages of
surviving mice out of n  10 mice subjected to infection with each gene-
deleted strain and H99, and n 5 or above for the complements. *Significant
difference in survival of mice infected with gene deletion mutant versus the
wild type or the complement strain; †Significant difference in survival of mice
infected with mutant strains compared to ena1-infected mice.clearance from the infected lungs (Figure 2C). Thus, theeffects of cryptococcal PIK1, RUB1, and ENA1 deletions
on pulmonary growth mirrored their effects on the overall
yeast virulence measured by host survival.
Cryptococcal PIK1, RUB1, and ENA1 Factors
Differentially Modulate Pathology in the Lungs
of Infected Mice
To evaluate how each of the cryptococcal genes of inter-
est contributed to the development of lung pathology,
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Figure 2. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on pul-
monary growth of C. neoformans. Lungs were harvested at days 3, 7, 14, and
21 postinfection with C. neoformans H99 (black bars in A, B, and C) or pik1
(A), rub1 (B), or ena1 (C) mutants, respectively. Panels B and C addi-
tionally show fungal burden in surviving mice at the conclusion of the
survival study (day 60). Note that all strains showed significantly decreased
fungal burden compared to H99 at all time points. Fungal burden of pik1
and rub1 were significantly higher than ena1 at days 14 and 21. Data are
expressed as the mean colony forming units (CFU) per lung  SEM; n  5
mice and above per time point per group. Mutant-infected groups signifi-
† ‡cantly different from *H99-, ena1-, and rub1-infected groups at the
matching time points.
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infected mice and around 60 dpi for infections with the
mutants. C. neoformans H99 induced severe lung pathol-
ogy, with organisms growing in virtually every area of the
lungs and displacing lung tissue (cryptococcomas) (Fig-
ure 3, A and B). Inflammatory infiltrates occupied the
margin of the infected areas, whereas the majority of
cryptococci resided within the alveolar space unaccom-
panied by host inflammatory cells, a hallmark of uncon-
trolled growth. The lungs infected with pik1 and H99
showed similar pathology; however, pathology took a
Figure 3. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on devel-
opment of pulmonary pathology in C. neoformans–infected mice. Lungs
were collected at day 21 from H99-infected mice (A and B) and at day 60
from pik1-infected (C and D), rub1-infected (E and F), and ena1-
infected (G and H) mice and processed for histology (H&E and mucicarmine
stains). The photographs were taken at 10 and 40 objective power. Note
that lungs infected with H99 and pik1 show similar pathological lesions (A
versus C at 10 power, and B versus D at 40 power), including wide-
spread C. neoformans organisms in the lungs (black arrows) and tissue
displacement by its rapid growth, and improved containment of the yeast
within the macrophages in lungs infected with rub1 (E and F), including
robust leukocyte infiltration (yellow arrows) with large macrophages. Note
that these macrophages are heavily laden with YM1/2 crystals (red arrows)
containing strongly stained fungal cells, characteristics of C. neoformans
harbored in alternatively activated macrophages. Note the absence of a
severe pathology or fungus in lungs infected with ena1 (G and H) and
focused mononuclear cell infiltrates consistent with a protective immune
response to C. neoformans.longer time to develop in pik1-infected lungs (Figure 3,C and D), indicating that like H99, pik1 can escape host
defenses, though with a substantial delay. The lesions in
lungs infected with rub1 were more densely consoli-
dated with numerous enlarged macrophages infiltrating
alveolar spaces (Figure 3, E and F). Cryptococci were
either contained within macrophages or surrounded by
dense inflammatory infiltrates, suggesting that the host
immune system recognized and attempted to control the
rub1 mutant. However, many macrophages appeared
to harbor live C. neoformans and/or were heavily laden
with chitinase-like protein (YM1/2) crystals, indicating that
they were alternatively or intermediately activated. These
pathological features of lung macrophages resembled
previously described pathologies found in chronic infec-
tion with cryptococcal persistence in the lungs and a
progressing, inefficient inflammatory reaction.5,7,9
In contrast with the severe lung pathologies induced
by pik1 and rub1 infections, ena1 infection produced
histological findings consistent with a protective immune
response. The majority of lungs were almost free of in-
flammation, with only occasional inflammatory foci repre-
sented by tight mononuclear cell infiltrates and no dis-
cernible yeasts, consistent with resolution of pneumonia
(Figure 3, G and H). Collectively, the pathological analy-
sis of infected lungs revealed that the type of lung pa-
thology that developed in response to each of the mutant
strains corresponded with the level of virulence as mea-
sured by yeast growth and survival.
Cryptococcal Genes PIK1, RUB1, and
ENA1 Have a Differential Impact on
Pulmonary Leukocyte Recruitment in
C. neoformans–Infected Lungs
Next, we characterized the compositions of the inflam-
matory responses to determine whether they correlate
with differences in the lung pathology and mutant persis-
tence. Flow cytometry and differential microscopic
counts were used to evaluate leukocyte populations in
the lungs at 21 dpi.
Flow cytometric analysis revealed significantly greater
numbers of leukocytes (CD45 cells) in the lungs of
H99-infected mice compared to lungs infected with the
mutants (Figure 4A). However, all mice infected with H99
and mutant strains showed similar numbers of CD4 T
cells (Figure 4B). Furthermore, significantly greater
numbers of CD8 T cells accumulated in the lungs
infected with the mutants compared to H99-infected
lungs (Figure 4C). Thus, deletions of PIK1, RUB1, and
ENA1 resulted in alleviated inflammatory responses with-
out reduced T-cell numbers, essential for anti-cryptococ-
cal protection.1,10,39,40 Improved control of the mutant
strains compared to H99 could be further explained by
greater CD8 T-cell numbers; however, variations in pul-
monary control of pik1, rub1, and ena1 were not due
to the differential CD8 T-cell recruitment.
Among myeloid subsets, the lowest percentage of lung
mononuclear phagocytes and the highest percentages of
eosinophils (a Th2 response marker) and neutrophils
were observed in H99-infected mice compared to pik1-,
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numbers of eosinophils and neutrophils were found in
lungs infected with pik1 or rub1, whereas ena1-in-
fected mice had the lowest numbers. Collectively, these
data imply that anti-cryptococcal immune responses in
the context of PIK1, RUB1, or ENA1 deletion were in-
creasingly more protective, as illustrated by decreasing
numbers of eosinophils and improved recruitment of
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Figure 4. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on CD45
cells and T lymphocyte recruitment in the lungs. Leukocytes were isolated
from the lungs of H99-, pik1-, rub1-, or ena1-infected mice at week 3
postinfection and then stained with specific antibodies. A: APC-labeled anti-
CD45 was used for leukocytes staining. B and C: The lymphocytes in the
preselected CD45 cell population were gated on forward and side scatter
plots, and the CD3 T cells were selected (Percp-Cy5.5); CD4 and CD8
subsets were identified using fluorescein isothiocyanate–labeled anti-CD8
(for Tc cells) or anti-CD4 antibodies (for Th cells) and calculated to express
a total number per lung. Note that pik1-, rub1-, or ena1-infected mice
had less inflammation in the lungs compared to the H99 group; however,
they show increased CD8 T-cell recruitment and equally robust CD4 T-cell
recruitment to the infected lungs at week 3. n  4 or more mice per group.
*Significantly different from H99-infected group.CD8 T cells.Cryptococcal Genes PIK1, RUB1, and ENA1
Have a Differential Impact on Cytokine
Responses during Pulmonary Infection
We next evaluated the effect of cryptococcal PIK1, RUB1,
and ENA1 deletions on pulmonary cytokine production.
We assessed the cytokine mRNA expression patterns in
leukocytes isolated from lungs infected with H99 or each
of the mutant strains. In general, mice infected with de-
letant strains still showed relatively high cytokine levels,
indicating an ongoing immune response in the infected
lungs. Consistent with improved pulmonary control of C.
neoformans, mutant strains elicited significantly lower ex-
pression of nonprotectiveTh2 cytokines, IL-4 and IL-13,
compared to H99-infected mice (Figure 6). Expression of
the Th1-driving IFN- tended to be elevated in leukocytes
from lungs infected with the mutant strains compared to
H99; however, this increase was significant in only the
rub1 group. Since, the antigen levels differed among
the groups, Th1/Th2 bias was normalized by calculating
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Figure 5. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on the
recruitment of myeloid leukocyte subsets to C. neoformans–infected lungs.
Leukocytes were isolated from the lungs of H99-, pik1-, rub1-, or ena1-
infected mice at week 3. Frequencies of each subset (left) were determined
by microscopic enumeration of cytospun leukocyte isolates and calculated
times the total CD45 cells per lung to evaluate total number (right). Note
that lungs infected with mutant strains had a significantly higher percentage
of mononuclear phagocytes and lower percentages of neutrophils and eo-
sinophils compared to H99-infected mice. All strains induced an equivalent
recruitment of mononuclear cells but showed decreasing total numbers of
neutrophils and eosinophils in order from highest to lowest virulence. n  4
mice or more per group; mutant-infected groups significantly different from
† ‡*H99-, ena1-, and rub1-infected groups. Mono & Mac, mononuclear
cells and macrophages.
IL-17
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Consistent with the least protective response in H99 in-
fection, we observed a strong Th2 bias (greatest IL-4/
IFN- ratio). The cytokine ratio in pik1-infected lungs
(the least attenuated) stayed close to a “neutral bias,”
whereas lungs infected with rub1 and ena1 showed a
robust shift toward a protective, Th1-biased cytokine profile
(lower IL-4/IFN- ratio). In addition, lungs infected with mu-
tant strains expressed significantly higher levels of protec-
tive, Th1-type cytokine TNF- compared to H99-infected
lungs, with most pronounced increase in the ena1 group,
correlating with themost effective clearance of the fungus in
these mice compared to the other groups.
The Th17 response has been shown to contribute to
anticryptococcal host defenses; however, IL-17 expres-
sion levels did not vary between H99 infection and those
infections with our mutant strains. Collectively, the cyto-
kine analysis demonstrates that expression of each of the
cryptococcal factors PIK1, RUB1, and ENA1 contributes
to the development of a nonprotective Th2 response
while opposing the protective Th1.
Cryptococcal Genes PIK1, RUB1, and ENA1
Have a Differential Impact on Pulmonary
Macrophage Activation Status
Macrophage activation is a critical functional step in clear-
ance of C. neoformans. To assess the M1/M2 macrophage
polarization status, we quantified the mRNA expression of
the M1 hallmark gene iNOS and the M2 hallmark Arg1 in
adherence-enriched pulmonary macrophages at 21 dpi
and calculated their expression ratio. Macrophages iso-
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‡lated from H99-infected lungs showed strong up-regulationof ARG1 and an ARG1/iNOS ratio above 8000, dramati-
cally skewed macrophage activation toward M2 polariza-
tion (Figure 7). By contrast, macrophages from lungs
infected with the mutant strains showed 100- to 200-fold
lower ARG1 expression levels than H99-infected lungs
(not shown). Furthermore, the ARG1/iNOS mRNA expres-
sion ratios showed a strong shift of macrophage activa-
tion in the rank order reflecting the level of protection,
such that the most effectively cleared ena1 mutant in-
duced the lowest ARG1/iNOS expression followed by the
†
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Figure 6. Effect of cryptococcal PIK1, RUB1, and ENA1
deletion on cytokine expression by pulmonary leukocytes
from C. neoformans–infected mice. RNA was isolated from
pulmonary leukocytes at week 3 postinfection, converted to
cDNA, and analyzed by quantitative PCR for the expression
of “Th polarizing” cytokines. Cytokine mRNA expression
level was normalized using a housekeeping gene (GAPDH)
and expressed as percent (relative expression). Note a highly
Th2-biased phenotype in the H99-infected group, a Th1-
biased cytokine profile in rub1- and ena1-infected
groups, and pik1 showing mixed cytokine phenotype. n 
5 of infected mice for each of the strains; mutant-infected
groups significantly different from *H99, †ena1, and ‡rub1
groups.
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Figure 7. Effect of cryptococcal PIK1, RUB1, and ENA1 deletion on macro-
phage activation profile in C. neoformans–infected lungs. mRNA was isolated
from adherence-enriched pulmonary macrophages at week 3 postinfection
and converted to cDNA. Arginase (ARG1) and nitric oxide synthase (iNOS)
expression levels were determined as in Figure 6, and the ratio between
Arg1/iNOS is shown as readout of M2 versus M1 macrophage activation
status. Note the profound M2 bias in macrophages from H99-infected lungs,
shift of the balance toward M1 in pik1-, rub1-, and ena1-infected groups,
with the ena1 group showing the most significant shift toward he M1 pheno-†
†
*type. n 5 or more infected mice for each of the strains; mutant-infected groups
significantly different from *H99- and †ena1-infected groups.
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infections with the more virulent rub1 and pik1 strains,
respectively (Figure 7). Thus, the shift in M1/M2 polariza-
tion in vivo that is associated with deletions of cryptococ-
cal PIK1, RUB1, and ENA1 precisely reflects the level of
virulence observed for each mutant.
Cryptococcal Genes PIK1, RUB1, and ENA1
Have a Differential Impact on Cryptococcal
Dissemination from the Infected Lungs
Our final goal in this study was to evaluate the impact of
cryptococcal PIK1, RUB1, and ENA1 deletions on ex-
trapulmonary dissemination and subsequent CNS inva-
sion of the yeast. H99 disseminated rapidly to the CNS,
showing the first positive brain cultures as early as 7 dpi
(Table 1). The H99 burdens at 21 dpi approached tissue
levels found in CNS postmortem, confirming that H99-
infected mice were dying from disseminated cryptococ-
cal disease. By contrast, the mutants showed nearly
complete protection from both splenic and CNS dissem-
ination during the initial 21 dpi. These outcomes changed
at the onset of mortalities for both pik1 and rub1 infec-
tions, which both displayed a robust potential to cause
disseminated extrapulmonary disease at later timepoints.
The pik1 brain and spleen postmortem fungal burdens
were 100% positive and were comparable to that of H99-
infected mice at death (Table 1). Mice infected with
rub1 demonstrated lower, but still considerable, fungal
burdens in brain and spleen at the time of death. Further-
more, mice succumbing to H99, pik1, or rub1 show
similar brain pathology, with large cystoid lesions con-
taining proliferating fungi consistent with the brain cul-
tures (Figure 8, A–C). By contrast, ena1 showed no po-
tential for causing extrapulmonary disease, evidenced by
negative cultures and the absence of brain pathology.
These results indicate that cryptococcal gene deletions of
PIK1, RUB1, and ENA1 interfere with the ability of C. neofor-
mans to disseminate or establish growth in extrapulmonary
sites, either delaying (PIK1, RUB1) or completely eliminating
Table 1. Effect of Cryptococcal PIK1, RUB1, and ENA1 Deletion
Organ and strain
Days
7
Spleen
H99 0 1
pik1 0
rub1 0
ena1 0
Brain
H99 0.68  0.43 2
pik1 0
rub1 0
ena1 0.32  0.32
Brains and spleens of the mice infected with pik1, rub1, ena1 muta
and at death for analysis of fungal burden. Data are expressed as the me
point).
*P  0.05 compared to H99 group.
†P  0.05 compared to pik1 group.(ENA1) extrapulmonary disease in mice.Discussion
This study shows that expression of cryptococcal genes
PIK1, RUB1, and ENA1 profoundly affects host immune
responses in the lungs, extrapulmonary dissemination,
and survival of C. neoformans–infected mice. Of the three
cryptococcal genes compared here, expression of ENA1
most profoundly promoted fungal virulence through the
induction of a nonprotective immune response; RUB1
exerted intermediate effects, and PIK1 expression had
the least pronounced effect on pathogenic properties of
the yeast. These outcomes expand on and clarify the
previously reported effects of these mutants displayed in
several acute screening assays.24 We demonstrate that
the major factor shaping the impact of these genes on the
e Extrapulmonary Dissemination of C. neoformans
nfection
Death21
0.33 3.37  0.34 3.37  0.5
0 3.58  0.3
0 2.42  0.22*†
0
0.82 4.99  0.94 5.92  0.26
0 5.61  0.41
0.33  0.33 3.75  0.52*†
0
d the wild-type strain H99 were harvested at days 7, 14, 21, postinfection
olony-forming units (CFU)  SEM (5 or more mice per group at each time
Figure 8. Effect of cryptococcal PIK1, RUB1, and ENA1 deletions on the
development of brain pathologies. Brains were collected at day 21 from
H99-infected mice (A) and at day 60 from pik1-infected (B), rub1-infected
(C), and ena1-infected (D) mice and processed for histology (H&E and
mucicarmine stains). Mice infected with pik1 or rub1 show similar path-
ological lesions in their brains as H99-infected mice, with large lesions in thes on th
post-i
14
.23 
0
0
0
.48 
0
0
0
nts, an
an log cbrain containing proliferating fungi in these mice (A–C); (D) ena1-infected
mice without brain pathology.
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tion of the adaptive immune responses and macrophage
activation status. We conclude that increasingly used
acute screening assays, although valuable, have some
limitations in predicting the overall effect of putative viru-
lence genes on host defenses and the clinical outcomes
in the infected mammalian host.
Our data show that the level of virulence attenuation of
the mutants measured as improved mice survival pre-
cisely matches the changes in kinetics of pulmonary
yeast growth, dissemination, and lung and brain histopa-
thology. These outcomes are consistent with analyzed
genes promoting pathogenic fitness of the organism
within the local environments present in the infected
host,23 as well as modulating the immunophenotype that
develops in infected mice. Deletion of PIK1, RUB1, and
ENA1 each differentially affected the balance of immune
polarization hallmark expression, including: Th1/Th2 cy-
tokine profiles; level of pulmonary eosinophilia and neu-
trophilia; and the pulmonary macrophage activation sta-
tus. The effects of these genes on the development of
pathological lesions in the lungs reflected the changes in
immune polarization. Such immunomodulatory effects of
cryptococcal virulence genes have been reported for
cryptococcal urease17 and phospholipase B.20 The pres-
ent study demonstrates that “immunomodulatory mech-
anisms” can be linked with a wider group of cryptococcal
virulence genes, and that the level and/or the type of
immunomodulation induced by each factor largely de-
fines the overall impact of each gene on the course of
cryptococcal disease.
We conclude that a broader scope of immunological
analyses is needed to establish a full impact of each
fungal factor. For example, Th1-promoting cytokine IFN-
has a well-established role in protection of the infected
host to C. neoformans, whereas Th2-driving IL-4 is known
to be detrimental4–6,9,16,31,41–43; however, our study
shows that narrowing analysis to just these two parame-
ters may be insufficient. On one hand, the comparison of
these cytokine responses in mice infected with H99 ver-
sus PIK1, RUB1, or ENA1 mutants demonstrated that
each of these factors contributed to a shifted IL-4/IFN-
ratio toward a Th2 response (Figure 6) and showed
changes proportional to the virulence composite dis-
played by strains H99, pik1, and rub1. However,
ena1 and rub1 show a different trend, with the former
having the strongest effect on fungal virulence, but a
lesser effect on IFN- and IL-4 production (Figures 1 and
6). The strongest effect of the ENA1 gene on cryptococ-
cal virulence can be attributed to its additional role in
reducing production of TNF-, which is essential for im-
mune protection against C. neoformans.44 The simultane-
ous increase in expression of both TNF- and IFN- in
response to cryptococcal ENA1deletion provides a com-
posite immunological explanation for the most prominent
role of ENA1 in H99 virulence among the factors analyzed
in this study.
Among various factors analyzed here, the readout of
M1/M2 polarization—ARG1/iNOS expression ratio—was
the most precise predictor of virulence potential dis-
played by these cryptococcal strains in vivo. Our datademonstrate that cryptococcal expression of PIK1,
RUB1, and ENA1 genes promote, to a varying degree,
the development of a nonprotective M2 pulmonary mac-
rophage phenotype. Deletions of each of these genes
resulted in a dramatic switch from the M2-polarized mac-
rophages in H99-infected mice to a protective M1 phe-
notype, with ENA1 gene deletion resulting in the most
M1-skewed phenotype, followed by RUB1 and lastly by
PIK1 deletion. This result supports the notion that relative
contributions of M1 and M2 phenotypes in the macro-
phages, shaped by the pulmonary cytokine environment,
is the major factor affecting cryptococcal clearance dy-
namics.6,9,10,45
Previous studies testing the fitness of various cryptococ-
cal strains using the in vitro macrophage assays proposed
that the level of cryptococcal resistance to the fungicidal
effect of macrophages in vitro correlated well with the
mortality of mice infected with these strains.28–30 Our
studies further clarified this point, demonstrating that
macrophage fungicidal assay in vitro is a good prelimi-
nary estimate of decreased virulence; however, it is not a
precise indicator of the attenuation level displayed by
each strain in vivo. Consistent with our previous report of
significantly decreased survival of pik1, rub1, and
ena1 mutants in the presence of IFN- activated mac-
rophages in vitro.24 we observed significantly decreased
virulence displayed by these strains in our mouse model
(Figure 1). However, the attenuation levels displayed by
these strains in the macrophage assay in vitro,24 as com-
pared to our outcomes in vivo, varied significantly. The
differences in outcomes of the “macrophage effect” of
these various virulence genes in vivo and in vitro can be
explained by differences in immunological microenviron-
ments. This is consistent with the current understanding
that macrophage phenotype functions as an “ultimate
readout” of integrated immunological signals, which re-
sults from various interactions between the yeast, mac-
rophage, and all other components of the immune sys-
tem.6,9–12 The in vitro assay can capture only some of
these interactions and cannot account for the dynamic
changes that occur during the immune response over
time. This view is further supported by analysis of histo-
pathological lesions observed 60 dpi in rub1-infected
lungs. The evident hallmarks of M2 (accumulation of both
YM1/2 crystals and live C. neoformans in macrophages)
suggest that macrophage activation status has not re-
mained M1 as observed at 21 dpi (Figure 8). The variable
level of rub1 control by the mice is reflected by its
pulmonary growth dynamics, which appeared more
static at times (from days 3 to 7 and days 14 to 21) in
contrast with steadily increasing H99 and pik1 fungal
burdens.
Comparison of our previously reported results to our
present in vivo infection data provides insight as to the
predictive capacity of other screening assays, including
tests of virulence in Caenorhabditis elegans infection and
growth within human CSF in vitro.24 In the C. elegans
infection assay used to identify fungal virulence factors,
especially those affecting the innate immune sys-
tem,26,46–48 pik1 and rub1 were attenuated.24 How-
ever, the ena1 strain showed wild-type virulence,24
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load postinoculation in mice (Figure 2C, day 3), which
can be attributed to the innate host defenses. Since C.
neoformans typically causes death by CNS infection, mi-
crobial growth in CSF would also be expected to corre-
spond to the ability of the fungus to cause mortality.
However, of all three strains preselected for their de-
creased ability to survive in CSF, only ena1 was unable
to establish an infection in the brain of infected mice.24
Despite their attenuation in CSF in vitro,24 pik1 and
rub1 were able to disseminate into the brain and cause
mortality in our murine model, although with a delay com-
pared to H99 infection. One explanation for this discrep-
ancy is differences in timing, which could allow for de-
velopment of compensatory mechanisms in this yeast
during prolonged infection. The extended time the mu-
tants persisted in the lung environment could promote the
development of compensatory mechanisms, which even-
tually enhanced yeast survival within the CNS. C. neofor-
mans has a strong potential for phenotypic and genotypic
switching, which are important components of cryptococ-
cal virulence.49–54
In terms of connection between the functions of PIK1,
RUB1, and ENA1 genes in cryptococcal physiology and
their effects leading to enhanced virulence, capsule for-
mation, melanin production, and the ability to grow at
37°C are well established as traits necessary for viru-
lence. In particular, melanin, and capsule polysaccha-
rides can have immunomodulatory effects.13,55,56 How-
ever, Lee et al.24 found that ena1 and pik1 strains show
normal phenotypes for these traits, suggesting that the
link for these two strains lies in other virulence pathways.
The rub1 strain did show partial temperature sensitivity
and reduced melanin production.24 Thus, the effects of
RUB1 on immune response and virulence could, to a
certain degree, be related to these virulence traits. How-
ever, up to this point, the connection between the func-
tion of PIK1, RUB1, and ENA1 genes in cryptococcal
physiology and their effects leading to the enhanced
virulence remains undefined and warrants future studies.
In conclusion, we demonstrate that the virulence genes
PIK1, RUB1, and ENA1 have significant, yet differential,
roles in the pathogenesis of pulmonary and disseminated
cryptococcosis. We demonstrate that cryptococcal PIK1,
RUB1, and ENA1 promote changes in the immune re-
sponses of the host, including alterations of Th polarization
and macrophage activation status. In contrast with previ-
ously reported screenings in which pik1, rub1, and
ena1 mutant attenuations were differently ranked with
various assays and/or analyzed time points,24 the in vivo
analysis in the mouse model yielded results that were
consistent across all host features, in terms of immune
polarization, macrophage activation status, pulmonary
growth, CNS dissemination, and mortality. Thus, screen-
ings of cryptococcal genes for virulence potential in sim-
plified assays need to be followed by analysis in a com-
plex mammalian system to determine their full impact on
different aspects of pathogenesis and the composite vir-
ulence of C. neoformans in the infected host.Acknowledgments
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